Gene expression can be altered by environmental factors such as food, drugs or exposure to toxins - and these changes can be passed on to our children.
Microfluids travel through channels thinner than a hair which can be made of glass, polymers, paper or gels and tiny valves can turn the flow on or off.
When we contract infectious diseases such as the flu, our cells can die to stop pathogens in their tracks before they spread further through our body.
Previously, bones that needed replacing would firstly need to be built in a laboratory. New technology means that, soon, it will be possible to ‘print’ bone tissue inside the body.
Members of the World Economic Forum's Global Future Council explore what's needed to realize synthetic biology's potential - and why we'll need to revisit and rethink the societal transfo...
A Singaporean start-up has set up the country's first urban insect farm, which extracts biomaterials to be used in pharmaceuticals and electronics.
The best photos of tiny things show nature’s beauty in stunning detail and could even help scientists find new treatments for diseases like Alzheimer’s.
Engineers at MIT and Imperial College London have developed a new way to generate tough, functional materials inspired by kombucha tea's fermentation process.
Derived from fungus, mycelium is proving to be a sustainable alternative material – in the worlds of fashion, packaging and food production.
A research team from the University of Texas at Austin have developed a new type of soil that can extract water straight from the air.
Researchers at MIT, MGH, and Harvard are now working on strategies for designing a universal flu vaccine, that could work against any flu strain.
A new research project, from the University of Washington, has found a way to use moths as potential couriers for tiny electronic packages.
Personalized medicine can play a big role in shaping a new healthcare model in MENA based on disease prevention - and this could bring significant benefits.
Genomics is emerging as a key source of data in healthcare. The benefits could be enormous, but we need to have a public debate about the risks and rewards.
There has never been a more important time to start a public conversation about genomics. Could a global PR campaign help to demystify this technology?